These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 31524)

  • 1. [Effect of atenolol in chronic pulmonary patients with airway obstruction].
    Vancrombreucq JC; Schandevyl W
    Lille Med; 1978; 23(7):506-12. PubMed ID: 31524
    [No Abstract]   [Full Text] [Related]  

  • 2. [Atenolol in the treatment of patients with airway obstruction].
    Chazan R
    Pol Merkur Lekarski; 1998 Feb; 4(20):89-91. PubMed ID: 9591440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta 1/beta 2-splitting of bisoprolol.
    Dorow P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S65-8. PubMed ID: 2439801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of a new cardioselective beta-adrenergic blocker (atenolol) on airway resistance in chronic obstructive disease (author's transl)].
    Beil M; Ulmer WT
    Arzneimittelforschung; 1977 Feb; 27(2):419-22. PubMed ID: 324487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possibilities of using cardioselective beta blocking agents in patients with chronic obstructive bronchopneumopathies].
    Giorgis GE; Galietti F; Miravalle C; Barberis S; Massaglia GM; Onoscuri E
    Minerva Med; 1986 Jun; 77(26):1255-8. PubMed ID: 2873530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension].
    Dorow P
    Arzneimittelforschung; 1987 Dec; 37(12):1370-2. PubMed ID: 2896506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the influence of the beta-blocker metoprolol on flow resistance of airways in patients with chronic obstructive disease of airways (author's transl)].
    Ulmer WT; Zimmerman I
    Arzneimittelforschung; 1980; 30(4):686-8. PubMed ID: 6994752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of beta 1-selective beta blockers in patients with obstructive airway diseases].
    Vankov T
    ZFA (Stuttgart); 1983 Apr; 59(10):611-4. PubMed ID: 6135285
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H; Schmidt J; Derendorf H
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atenolol in treatment of patients with airway obstruction].
    Chazan R
    Pol Merkur Lekarski; 1996 Dec; 1(6):428-30. PubMed ID: 9273241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled trial on three beta-blockers: antihypertensive efficacy and effect on the hypertensive heart disease.
    Pupita F; Ansuini R; Belogi M; Pupita G; Gaggi S
    Int J Clin Pharmacol Res; 1985; 5(6):439-45. PubMed ID: 2869001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects on airway conductance of a new selective beta-adrenergic blocking drug, atenolol, and propranolol in asthmatic subjects.
    Aström H
    Scand J Respir Dis; 1975; 56(6):292-6. PubMed ID: 1221496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celiprolol and atenolol in angina--effects on left ventricular function.
    Dargie H; McLenachan JM; Wilson JT
    J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of smooth muscle contraction: relevance to safety of beta-adrenergic blockade in hypertensive patients with reversible chronic obstructive airways disease.
    Opie LH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S43-7. PubMed ID: 2427852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
    Kukes VG; Ostroumova OD; Mamaev VI; Batutina AM; Abakumov IuE; Zykova AA
    Ter Arkh; 2003; 75(8):43-7. PubMed ID: 14520850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.
    Schiess W; Dorow P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S30-3. PubMed ID: 2439815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris.
    Dorow P; Bethge H; Tönnesmann U
    Eur J Clin Pharmacol; 1986; 31(2):143-7. PubMed ID: 2879733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of a new beta-blocking drug (atenolol, ICI 66082) in treating arterial hypertension].
    Cerasola GA; Botta RM; Riolo A; Amico LM
    Boll Soc Ital Cardiol; 1979; 24(5):493-500. PubMed ID: 553637
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of atenolol on airway resistance in hypertensive patients with chronic obstructive lung disease].
    Molho M; Lidgy M; Ezra D; Rosenthal T
    Harefuah; 1981 Mar; 100(5):220-2. PubMed ID: 7286815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.